RegenLab, a leading force in regenerative medicine and cellular therapy, has announced a significant expansion in its North American operations with the appointment of Plasmatology Group as its exclusive distributor for the Canadian aesthetic market. The move positions RegenLab to strengthen its footprint in aesthetic medicine across Canada, offering advanced regenerative solutions to clinics and practitioners seeking cutting-edge treatments. For more insights into health and wellness developments in New Jersey and beyond, visit https://explorenewjersey.org/category/health-wellness/
Headquartered in Jersey City, New Jersey, RegenLab USA operates as the American arm of Regen Lab SA, the Swiss-based parent company founded in 2003. The organization has built a global reputation for pioneering regenerative therapies, focusing on platelet-rich plasma (PRP) technologies and other cellular innovations that promote tissue healing, rejuvenation, and wellness.
In early 2024, RegenLab USA made a strategic move from New York City to 95 Greene Street in Jersey City, signaling a commitment to expanding its American operations. The transition laid the groundwork for a cutting-edge research, development, and manufacturing facility, officially opened in June 2025. The new facility not only provides state-of-the-art laboratories and production capabilities but also highlights New Jersey’s growing status as a hub for life sciences and biomedical innovation.
Plasmatology Group, now serving as RegenLab’s exclusive Canadian partner for aesthetic applications, will provide clinics and practitioners with access to the company’s full line of regenerative products, including PRP kits and cellular therapy solutions. This partnership underscores the increasing demand for non-invasive, regenerative procedures across North America and reflects a broader trend in the aesthetic and wellness sectors toward scientifically driven, clinically validated treatments.
Executives at RegenLab emphasized that this move strengthens their commitment to delivering advanced regenerative medicine solutions to the North American market while leveraging the expertise and distribution network of Plasmatology Group to reach clinics and medical professionals across Canada efficiently. The company continues to focus on innovation, quality, and training for practitioners to ensure safe and effective treatment outcomes.
With its expanded operations in Jersey City and now a direct link into Canada via Plasmatology Group, RegenLab is well-positioned to serve a growing clientele seeking next-generation regenerative therapies. The company’s growth reflects both the robust potential of regenerative medicine and New Jersey’s emergence as a central hub for biomedical research, development, and manufacturing.
Practitioners and patients alike can expect increased access to RegenLab’s portfolio of products designed to support aesthetic enhancements, tissue regeneration, and overall wellness. The collaboration with Plasmatology Group ensures that Canadian clinics will now benefit from the same high-quality regenerative solutions already established in the United States and around the globe.
For more updates on regenerative medicine, cellular therapy, and the latest trends in health and wellness, explore https://explorenewjersey.org/category/health-wellness/
